You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Details for Patent: 9,320,455


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,320,455
Title:Highly reliable ingestible event markers and methods for using the same
Abstract: Ingestible event markers having high reliability are provided. Aspects of the ingestible event markers include a support, a control circuit, a first electrochemical material, a second electrochemical material and a membrane. In addition, the ingestible event markers may include one or more components that impart high reliability to the ingestible event marker. Further, the ingestible event markers may include an active agent. In some aspects, the active agent, such as a pharmaceutically active agent or a diagnostic agent may be associated with the membrane.
Inventor(s): Hafezi; Hooman (Redwood City, CA), Au-Yeung; Kityee (San Francisco, CA), Duck; Robert (San Francisco, CA), Holen; Maria Casillas (Santa Clara, CA), Robertson; Timothy (Belmont, CA), Costello; Benedict James (Berkeley, CA)
Assignee: Proteus Digital Health, Inc. (Redwood City, CA)
Application Number:13/756,280
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,320,455

To delve into the specifics of United States Patent 9,320,455, it is crucial to analyze the patent's claims, the technological context, and the broader patent landscape. Here is a detailed breakdown of these aspects.

Patent Overview

United States Patent 9,320,455, like any other patent, is a grant of rights for an invention, and its scope is defined by its claims. The claims are the legal boundaries of what the patent protects.

Claims Analysis

Independent and Dependent Claims

  • Independent Claims: These are the broadest claims in the patent and define the core invention. They stand alone and do not rely on other claims for their validity.
  • Dependent Claims: These claims build upon the independent claims and add additional limitations. They are narrower and often provide more specific embodiments of the invention[4].

Claim Construction

The construction of claims is critical in determining the patent's scope. This involves interpreting the language of the claims to understand what is covered and what is not. The USPTO and courts use various tools and guidelines, such as the Federal Circuit's decisions, to ensure consistent and clear application of patent eligibility criteria[1].

Technological Context

Field of the Invention

Understanding the field in which the patent operates is essential. For example, if the patent is related to AI technologies, the recent USPTO guidance update on AI patent eligibility would be relevant. This update clarifies how AI-related inventions are evaluated for patent eligibility, emphasizing the integration of judicial exceptions into practical applications[1].

Prior Art and Novelty

The patent must be novel and non-obvious over the prior art. This means that the invention must be new and not obvious to someone skilled in the relevant field. The patent's claims must distinguish the invention from existing technologies and innovations[4].

Patent Landscape

Competing Patents and Applications

Analyzing the patent landscape involves looking at other patents and applications in the same field. Tools like the USPTO's Global Dossier and Common Citation Document (CCD) can help in identifying related applications and prior art cited by various patent offices. This can provide insights into the competitive environment and potential challenges or opportunities[4].

Litigation and Enforcement

The enforceability of the patent is another crucial aspect. Cases like In Re FLOAT'N'GRILL LLC highlight the importance of ensuring that reissue claims comply with statutory requirements, such as the "original patent" requirement under 35 U.S.C. § 251. This ensures that the claims do not exceed the scope of the original invention[5].

Economic and Strategic Implications

Market Impact

The patent's scope and claims can significantly impact the market. For instance, if the patent covers a critical technology, it could give the patent holder a competitive advantage. The economic implications can be substantial, affecting not only the patent holder but also competitors and consumers.

Licensing and Collaboration

The patent's claims can also influence licensing agreements and collaborative efforts. Clear and well-defined claims can facilitate negotiations and ensure that all parties understand what is protected and what is not.

Recent Developments and Guidance

USPTO Guidance on AI Patents

The 2024 USPTO guidance update on AI patents is particularly relevant for patents involving AI technologies. This guidance provides new examples and clarifies how AI-assisted inventions are evaluated, ensuring they are treated on equal footing with other technologies. It emphasizes the importance of integrating judicial exceptions into practical applications to meet patent eligibility criteria[1].

Small Claims Patent Court

There are ongoing discussions and studies about the feasibility of a small claims patent court, which could impact the enforcement and litigation landscape for patents. This could provide a more accessible and cost-effective way for smaller entities to resolve patent disputes[2].

Data and Analytics

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset can provide valuable insights into patent scope and trends. This dataset includes detailed information on claims from US patents and applications, which can be used to analyze the breadth and depth of patent protection[3].

Key Takeaways

  • Claims Construction: The claims define the legal boundaries of the patent and must be carefully constructed and interpreted.
  • Technological Context: Understanding the field of the invention and recent developments, such as the USPTO guidance on AI patents, is crucial.
  • Patent Landscape: Analyzing competing patents and applications helps in understanding the competitive environment.
  • Economic and Strategic Implications: The patent's scope can have significant market and economic implications.
  • Recent Developments: Keeping abreast of updates like the USPTO guidance on AI patents and potential changes in the patent litigation landscape is essential.

FAQs

What is the significance of the USPTO's 2024 guidance update on AI patents?

The update clarifies the process for determining the patent eligibility of AI-related inventions, emphasizing the integration of judicial exceptions into practical applications and ensuring AI-assisted inventions are evaluated on equal footing with other technologies[1].

How do dependent claims differ from independent claims?

Dependent claims build upon independent claims and add additional limitations, making them narrower and more specific embodiments of the invention[4].

What is the purpose of the Global Dossier service provided by the USPTO?

The Global Dossier service allows users to access the file histories of related applications from participating IP Offices, providing a single portal for viewing patent family information, classification, and citation data[4].

Why is the "original patent" requirement important in reissue claims?

The "original patent" requirement ensures that reissue claims do not exceed the scope of the original invention, as mandated by 35 U.S.C. § 251. This prevents broadening the claims beyond what was originally disclosed[5].

How can the Patent Claims Research Dataset be useful for patent analysis?

The dataset provides detailed information on claims from US patents and applications, allowing for the analysis of patent scope and trends, which can be invaluable for understanding the breadth and depth of patent protection[3].

Cited Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz.
  2. U.S. Patent Small Claims Court - ACUS.
  3. Patent Claims Research Dataset - USPTO.
  4. Search for patents - USPTO - USPTO.
  5. In Re FLOAT'N'GRILL LLC - Court of Appeals for the Federal Circuit.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,320,455

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-001 Nov 13, 2017 RX Yes No 9,320,455 ⤷  Subscribe Y ⤷  Subscribe
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-002 Nov 13, 2017 RX Yes Yes 9,320,455 ⤷  Subscribe Y ⤷  Subscribe
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-003 Nov 13, 2017 RX Yes No 9,320,455 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.